Sonoma Pharmaceuticals, Inc.
SNOA
$1.10
-$0.03-2.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.40M | 2.56M | 3.04M | 3.61M | 5.37M |
| Total Receivables | 2.61M | 2.53M | 2.91M | 2.83M | 2.44M |
| Inventory | 3.65M | 3.70M | 3.63M | 3.80M | 2.92M |
| Prepaid Expenses | 3.44M | 3.35M | 2.93M | 2.87M | 1.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.10M | 12.15M | 12.50M | 13.11M | 12.65M |
|
|
|||||
| Total Current Assets | 12.10M | 12.15M | 12.50M | 13.11M | 12.65M |
| Net Property, Plant & Equipment | 912.00K | 956.00K | 763.00K | 837.00K | 309.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 948.00K | 522.00K | 592.00K | 650.00K | 736.00K |
| Total Assets | 13.96M | 13.62M | 13.86M | 14.59M | 13.69M |
|
|
|||||
| Total Accounts Payable | 1.92M | 1.65M | 1.40M | 2.05M | 953.00K |
| Total Accrued Expenses | 1.72M | 2.11M | 2.02M | 1.84M | 1.74M |
| Short-term Debt | 222.00K | -- | 56.00K | 139.00K | 220.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 151.00K | 146.00K | 88.00K | 96.00K | 58.00K |
| Total Finance Division Other Current Liabilities | 817.00K | 314.00K | 750.00K | 731.00K | 1.13M |
| Total Other Current Liabilities | 817.00K | 314.00K | 750.00K | 731.00K | 1.13M |
| Total Current Liabilities | 4.83M | 4.22M | 4.32M | 4.85M | 4.10M |
|
|
|||||
| Total Current Liabilities | 4.83M | 4.22M | 4.32M | 4.85M | 4.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 222.00K | -- | 56.00K | 139.00K | 220.00K |
| Capital Leases | 469.00K | 509.00K | 391.00K | 440.00K | 27.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.56M | 5.47M | 5.36M | 5.25M | 5.16M |
| Total Liabilities | 10.87M | 10.19M | 10.07M | 10.54M | 9.28M |
|
|
|||||
| Common Stock & APIC | 207.32M | 207.02M | 206.73M | 206.67M | 206.59M |
| Retained Earnings | -200.98M | -200.40M | -199.58M | -199.05M | -197.81M |
| Treasury Stock & Other | -3.24M | -3.19M | -3.37M | -3.57M | -4.38M |
| Total Common Equity | 3.10M | 3.43M | 3.79M | 4.06M | 4.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.10M | 3.43M | 3.79M | 4.06M | 4.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.10M | 3.43M | 3.79M | 4.06M | 4.41M |
|
|
|||||